Selank

Approved (Russia/Ukraine)

Selank (TP-7)

Aliases
TP-7, Selanc
Administration
Intranasal spray, Subcutaneous injection

Documented side effects

Tier 1 · Peer-reviewed / regulatory

Mild fatigue

A modest sense of tiredness reported by some users.

Excellent overall safety profile

Represents one of the more favorable safety profiles reported for peptides in this category.